What is the recommended dose of acyclovir (antiviral medication) for herpes zoster?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acyclovir Dosing for Herpes Zoster

For herpes zoster (shingles), the recommended dose is acyclovir 800 mg orally five times daily for 7 to 10 days. 1

Standard Oral Dosing Regimen

  • Acyclovir 800 mg orally every 4 hours (5 times daily) for 7-10 days is the FDA-approved and guideline-recommended dose for acute herpes zoster treatment 1
  • This high-dose regimen (800 mg five times daily) is superior to lower doses (400 mg five times daily) and significantly alters the course of disease 2
  • Treatment accelerates rash healing, reduces viral shedding, decreases new lesion formation, and shortens the duration of acute pain 2, 3

Impact on Post-Herpetic Neuralgia

  • The 800 mg five times daily regimen reduces the incidence and duration of post-herpetic neuralgia, shortening pain duration from an average of 86 days to 49 days (p<0.001) 4
  • Treatment reduces the weekly prevalence of pain by the fourth week and decreases chronic pain prevalence in months 2-3 3
  • The effect on post-herpetic neuralgia is most significant when treatment is initiated within 72 hours of rash onset 5

Timing of Treatment Initiation

  • Treatment must be started as early as possible, ideally within 72 hours of rash onset, for maximum benefit in preventing complications 5
  • Early treatment significantly reduces the incidence and severity of common complications including dendritiform keratopathy, stromal keratitis, and uveitis in herpes zoster ophthalmicus 5

Severe Disease and Intravenous Therapy

  • For severe disease, complications, or hospitalized patients, use acyclovir 5-10 mg/kg IV every 8 hours for 5-7 days or until clinical improvement 6
  • IV therapy is indicated for disseminated infection, pneumonitis, hepatitis, or CNS complications 6

Special Populations: Immunocompromised Patients

  • Immunocompromised patients require more aggressive therapy with higher doses or IV administration 6
  • These patients may need prolonged treatment courses and potentially suppressive therapy with acyclovir 400 mg orally 3-5 times daily 6

Renal Dose Adjustments

  • For creatinine clearance 10-25 mL/min: reduce to 800 mg every 8 hours 1
  • For creatinine clearance 0-10 mL/min: reduce to 800 mg every 12 hours 1
  • For hemodialysis patients, administer an additional dose after each dialysis session due to 60% decrease in plasma concentrations during a 6-hour dialysis period 1

Common Pitfalls to Avoid

  • Never use topical acyclovir for herpes zoster—it is substantially less effective than oral therapy and should not be used 6
  • Do not use the lower 400 mg five times daily dose, as studies show this regimen does not achieve statistical significance compared to placebo 2
  • Acyclovir does not eradicate latent virus and does not prevent future recurrences 6

Alternative Agents with Superior Convenience

  • Valacyclovir 1,000 mg three times daily for 7 days offers equivalent or superior efficacy with simpler dosing (three times daily versus five times daily) and accelerates pain resolution compared to acyclovir 7
  • Valacyclovir reduces the proportion of patients with pain persisting for 6 months (19.3% versus 25.7% with acyclovir) 7

References

Research

Therapy of herpes zoster with oral acyclovir.

The American journal of medicine, 1988

Research

Zoster-associated chronic pain: an overview of clinical trials with acyclovir.

Scandinavian journal of infectious diseases. Supplementum, 1991

Guideline

Acyclovir Dosing for Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.